Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
2 pending office actions • 1 art units • 1 examiners • 0 of 2 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Anaconda Biomed, S.L. is active in the Medical Devices & Mechanical Engineering technology area. The company currently has 2 pending office actions. These actions are assigned to 1 distinct examiner and are situated within 1 distinct art unit. This indicates a high degree of concentration in the company's prosecution efforts, as multiple pending matters are being reviewed by the same individual.
The busiest examiner for this portfolio is HOLWERDA, KATHLEEN SONNETT. This examiner is responsible for 2 pending office actions. Since there is only 1 distinct examiner for the portfolio, HOLWERDA, KATHLEEN SONNETT manages all 2 pending office actions. This represents a complete concentration of the company's current prosecution efforts under a single individual and art unit. For practitioners, this means that the examiner's perspective will be decisive for the entirety of the company's pending applications. The consistency of having 2 pending office actions with 1 distinct examiner may facilitate a more unified negotiation process during prosecution.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HOLWERDA, KATHLEEN SONNETT | 2 | 68.7% | +17.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18546206 | A SELF-EXPANDABLE MEDICAL DEVICE FOR ADVANCEMENT THROUGH VASCULATURE TO AN EXPANSION SITE IN A BLOOD VESSEL | HOLWERDA, KATHLEEN SONNETT | 38d overdue |
| 18546190 | AN EXPANDABLE CLOT MOBILIZER DEVICE FOR EXTRACTION OF AN OCCLUSION FROM A BLOOD VESSEL | HOLWERDA, KATHLEEN SONNETT | 38d overdue |
| Art Unit | Apps |
|---|---|
| 3771 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18546206 | A SELF-EXPANDABLE MEDICAL DEVICE FOR ADVANCEMENT THROUGH VASCULATURE TO AN EXPANSION SITE IN A BLOOD VESSEL | HOLWERDA, KATHLEEN SONNETT | 3771 | §103 | Non-Final OA | 38d overdue | Pending | Aug 11, 2023 |
| 18546190 | AN EXPANDABLE CLOT MOBILIZER DEVICE FOR EXTRACTION OF AN OCCLUSION FROM A BLOOD VESSEL | HOLWERDA, KATHLEEN SONNETT | 3771 | §103 | Final Rejection | 38d overdue | Pending | Aug 11, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial